Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
The PD-L1 inhibitor Bavencio, when given as maintenance therapy to gastric cancer patients in a trial, was not superior to chemotherapy, but... Read More
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
In a recent trial, Keytruda was found to be as effective as chemotherapy in previously untreated gastric cancer patients, but it caused... Read More
Cancer patients who exercise have less heart damage from chemotherapy
A paper published by the European Journal of Preventative Cardiology reports that cancer patients who exercise have less heart damage from chemotherapy... Read More
Predictors of Response to Immune Checkpoint Inhibitors in Patients With Advanced Esophagogastric Cancer
In a recent trial of checkpoint inhibitors in gastric or esophageal cancer, patients who reported immune-related side effects also showed longer survival... Read More
Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer
In a recent study, patients with gastrointestinal cancers who had immune-related adverse events while taking checkpoint inhibitors had progression-free survival of 32... Read More
Nutrition for Patients With Mucositis
Dr. Jann Arends discusses the importance of considering nutritional treatment for #cancer patients with mucositis, painful inflammation and ulceration of the mucous... Read More
Women more prone to selected oesophagogastric cancer chemotherapy side-effects
New research presented at ESMO investigates whether men and women should be treated differently in cancer care, finding women are more prone... Read More
